Stockreport

IO Biotech Provides Corporate Update

IO Biotech, Inc.  (IOBT) 
PDF Raymond James engaged as financial advisorReduction in force implemented NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biop [Read more]